Arax Advisory Partners’s Akero Therapeutics AKRO Stock Holding History

Arax Advisory Partners’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-111	Closed	-$5.27K	–	4088
2025 Q3	$5.27K	Buy	+111	New	+$5.38K	﹤0.01%	2854
2025 Q1	–	Sell	-22	Closed	-$613	–	2672
2024 Q4	$613	Buy	+22	New	+$666	﹤0.01%	2284

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arax Advisory Partners's AKRO Position: Q4 2025 in Review

Arax Advisory Partners sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 111 shares — an estimated $5.27K sold.

Arax Advisory Partners first reported a position in AKRO in Q4 2024 and held it in 2 quarters. The position peaked at $5.27K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Arax Advisory Partners reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 111 Akero Therapeutics shares in Q4 2025, an estimated $5.27K.
Arax Advisory Partners first reported a position in Akero Therapeutics in Q4 2024 and held it in 2 quarters.
Arax Advisory Partners's Akero Therapeutics position peaked at $5.27K in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.